Imunon, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
Imunon, Inc. (IMNN) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $72.09 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-12.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2015-03-12
- Imunon, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2014 was $72.09K, a 60.83% decline from fiscal 2013.
- Imunon, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2013 was $184.05K, a 73.60% decline from fiscal 2012.
- Imunon, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2012 was $697.22K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month |
|---|---|
| 2014-12-31 | $72.09K 10-K · filed 2015-03-12 |
| 2013-12-31 | $184.05K 10-K · filed 2015-03-12 |
| 2012-12-31 | $697.22K 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |